APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 41 filers reported holding APREA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 3.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $91,309 | -54.8% | 275,860 | -11.6% | 0.00% | – |
Q3 2022 | $202,000 | -23.5% | 312,016 | -11.3% | 0.00% | – |
Q2 2022 | $264,000 | -42.5% | 351,836 | +42.5% | 0.00% | – |
Q1 2022 | $459,000 | -51.0% | 246,944 | -24.3% | 0.00% | – |
Q4 2021 | $936,000 | -1.0% | 326,210 | +76.4% | 0.00% | – |
Q3 2021 | $945,000 | -81.0% | 184,964 | -81.9% | 0.00% | -100.0% |
Q2 2021 | $4,975,000 | -2.3% | 1,019,776 | +2.2% | 0.00% | 0.0% |
Q1 2021 | $5,090,000 | +118.7% | 998,127 | +111.0% | 0.00% | – |
Q4 2020 | $2,327,000 | +42.8% | 473,021 | +597.9% | 0.00% | – |
Q3 2020 | $1,630,000 | -40.5% | 67,774 | -4.1% | 0.00% | -100.0% |
Q2 2020 | $2,740,000 | +16017.6% | 70,660 | +14032.0% | 0.00% | – |
Q1 2020 | $17,000 | -97.2% | 500 | -96.3% | 0.00% | – |
Q4 2019 | $615,000 | – | 13,398 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 1,259,662 | $6,437,000 | 2.66% |
COASTAL INVESTMENT MANAGEMENT, L.P. | 41,965 | $214,000 | 0.30% |
Redmile Group, LLC | 694,918 | $3,551,000 | 0.06% |
Quantamental Technologies LLC | 13,752 | $70,000 | 0.05% |
KENNEDY CAPITAL MANAGEMENT LLC | 342,486 | $1,750,000 | 0.04% |
PDT Partners, LLC | 87,734 | $448,000 | 0.03% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 75,000 | $383,000 | 0.01% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 49,100 | $251,000 | 0.01% |
NEXT Financial Group, Inc | 11,347 | $58,000 | 0.01% |
Sugarloaf Wealth Management, LLC | 1,500 | $8,000 | 0.00% |